These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27815681)

  • 1. Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications.
    Kim JH; Shah P; Tantry US; Gurbel PA
    Curr Heart Fail Rep; 2016 Dec; 13(6):319-328. PubMed ID: 27815681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives.
    Gurbel PA; Tantry US
    JACC Heart Fail; 2014 Feb; 2(1):1-14. PubMed ID: 24622113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do anticoagulants or antiplatelet drugs have a role in treating heart failure in the absence of atrial fibrillation?
    Gouda P; Ezekowitz JA
    Clin Pharmacol Ther; 2013 Oct; 94(4):435-8. PubMed ID: 24048238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Coagulation Disorders in Heart Failure: From Basic Science to Clinical Perspectives.
    Siniarski A; Gąsecka A; Borovac JA; Papakonstantinou PE; Bongiovanni D; Ehrlinder H; Giustozzi M; Guerreiro RA; Parker WAE
    J Card Fail; 2023 Apr; 29(4):517-526. PubMed ID: 36632933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation Therapy and NOACs in Heart Failure.
    Thomas I; EncisoSilva J; Schlueter M; Greenberg B
    Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation in heart failure: current status and future direction.
    Gheorghiade M; Vaduganathan M; Fonarow GC; Greene SJ; Greenberg BH; Liu PP; Massie BM; Mehra MR; Metra M; Zannad F; Cleland JG; van Veldhuisen DJ; Shah AN; Butler J
    Heart Fail Rev; 2013 Nov; 18(6):797-813. PubMed ID: 22987320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Ponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marin F; Lane DA;
    Eur J Heart Fail; 2012 Jul; 14(7):681-95. PubMed ID: 22611046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercoagulability in heart failure.
    Jafri SM
    Semin Thromb Hemost; 1997; 23(6):543-5. PubMed ID: 9469627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy for heart failure in sinus rhythm.
    Subramaniam V; Davis RC; Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological prevention of thromboembolism in patients with left ventricular dysfunction.
    Thatai D; Ahooja V; Pullicino PM
    Am J Cardiovasc Drugs; 2006; 6(1):41-9. PubMed ID: 16489847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and adherence to guidelines of antithrombotic therapy in Thai patients with nonvalvular atrial fibrillation.
    Jedsadayanmata A
    J Med Assoc Thai; 2013 Jan; 96(1):91-8. PubMed ID: 23720984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Therapy for Heart Failure in Sinus Rhythm - A Concise Review.
    Sharma R; Subedi A
    S D Med; 2024 May; 77(5):213-219. PubMed ID: 39012774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation in patients with heart failure.
    Bhatia RS; Ouzounian M; Tu JV; Liu PP; Lee DS
    Cardiovasc Hematol Agents Med Chem; 2009 Jul; 7(3):193-7. PubMed ID: 19689257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure.
    Garg RK; Gheorghiade M; Jafri SM
    Prog Cardiovasc Dis; 1998; 41(3):225-36. PubMed ID: 9872608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in management of atrial fibrillation in patients with heart failure.
    Shantsila E; Lip GY
    Curr Opin Cardiol; 2013 Mar; 28(2):197-208. PubMed ID: 23385332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice.
    Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P
    Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.